Skip to main content
Veterinary Medicines

POLYPLEUROSIN APN PLUS IM

Authorised
  • Pasteurella multocida, serogroup D, Inactivated
  • Pasteurella multocida, serogroup A, Inactivated
  • Bordetella bronchiseptica, Inactivated
  • Actinobacillus pleuropneumoniae, serovar 9, strain App9KL97, Inactivated
  • Actinobacillus pleuropneumoniae, serovar 2, strain App2TR98, Inactivated
  • Actinobacillus pleuropneumoniae, APX III toxoid
  • Actinobacillus pleuropneumoniae, APX I toxoid
  • Actinobacillus pleuropneumoniae, APX II toxoid

Product identification

Medicine name:
POLYPLEUROSIN APN PLUS IM
Active substance:
  • Pasteurella multocida, serogroup D, Inactivated
  • Pasteurella multocida, serogroup A, Inactivated
  • Bordetella bronchiseptica, Inactivated
  • Actinobacillus pleuropneumoniae, serovar 9, strain App9KL97, Inactivated
  • Actinobacillus pleuropneumoniae, serovar 2, strain App2TR98, Inactivated
  • Actinobacillus pleuropneumoniae, APX III toxoid
  • Actinobacillus pleuropneumoniae, APX I toxoid
  • Actinobacillus pleuropneumoniae, APX II toxoid
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Pasteurella multocida, serogroup D, Inactivated
    1.00
    relative potency
    /
    1.00
    millilitre(s)
  • Pasteurella multocida, serogroup A, Inactivated
    1.00
    relative potency
    /
    1.00
    millilitre(s)
  • Bordetella bronchiseptica, Inactivated
    1.00
    relative potency
    /
    1.00
    millilitre(s)
  • Actinobacillus pleuropneumoniae, serovar 9, strain App9KL97, Inactivated
    1.00
    relative potency
    /
    1.00
    millilitre(s)
  • Actinobacillus pleuropneumoniae, serovar 2, strain App2TR98, Inactivated
    1.00
    relative potency
    /
    1.00
    millilitre(s)
  • Actinobacillus pleuropneumoniae, APX III toxoid
    1.00
    relative potency
    /
    1.00
    millilitre(s)
  • Actinobacillus pleuropneumoniae, APX I toxoid
    1.00
    relative potency
    /
    1.00
    millilitre(s)
  • Actinobacillus pleuropneumoniae, APX II toxoid
    1.00
    relative potency
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AB
Authorisation status:
  • Valid
Authorised in:
  • Romania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • Institute For Control Of Biological Products And Veterinary Medicines
Authorisation number:
  • 120238
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Romanian (PDF)
Published on: 12/01/2022